These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31102172)

  • 41. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromogranin A does not mediate glucocorticoid inhibition of adrenocorticotropin secretion.
    Horiba N; Nicholson WE; Ch'ng JL; Orth DN
    Endocrinology; 1993 Apr; 132(4):1585-92. PubMed ID: 8384991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Imatinib Combined With Everolimus on Mouse Pituitary Tumor Cell AtT-20.
    Wang W; Lin Y; Qu X; Meng L; Yang J
    Altern Ther Health Med; 2023 Jan; 29(1):238-244. PubMed ID: 36150015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cushing's syndrome in a 16 year old girl due to ectopic ACTH precursor production from a pancreatic tumour.
    Hinnie J; Gray CE; McNicol AM; Carter R; Thomson JA; White A; Campbell IW; McBain A
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):539-40. PubMed ID: 11012582
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
    Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
    Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma.
    Alwani RA; Neggers SJ; van der Klift M; Baggen MG; van Leenders GJ; van Aken MO; van der Lely AJ; de Herder WW; Feelders RA
    Pituitary; 2009; 12(3):280-3. PubMed ID: 18322802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.
    Molè D; Gagliano T; Gentilin E; Tagliati F; Pasquali C; Ambrosio MR; Pansini G; Degli Uberti EC; Zatelli MC
    Endocr Relat Cancer; 2011 Aug; 18(4):439-50. PubMed ID: 21606156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo.
    Burrin JM; Yeo TH; Ashby MJ; Bloom SR
    J Endocrinol; 1986 Jan; 108(1):37-41. PubMed ID: 3003220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome.
    Jimenez Reina L; Leal-Cerro A; Garcia J; Garcia-Luna PP; Astorga R; Bernal G
    Acta Endocrinol (Copenh); 1989 Aug; 121(2):185-90. PubMed ID: 2549753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrence of a neuroendocrine tumor of adrenal origin: a case report with more than a decade follow-up.
    Rahmani F; Tohidi M; Dehghani M; Broumand B; Hadaegh F
    BMC Endocr Disord; 2021 Jan; 21(1):9. PubMed ID: 33413271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
    Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
    Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
    Siddique ZL; Drozdov I; Floch J; Gustafsson BI; Stunes K; Pfragner R; Kidd M; Modlin IM
    Neuroendocrinology; 2009; 89(4):458-70. PubMed ID: 19295186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoic acid prevents experimental Cushing syndrome.
    Páez-Pereda M; Kovalovsky D; Hopfner U; Theodoropoulou M; Pagotto U; Uhl E; Losa M; Stalla J; Grübler Y; Missale C; Arzt E; Stalla GK
    J Clin Invest; 2001 Oct; 108(8):1123-31. PubMed ID: 11602619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
    BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Appendiceal Neuroendocrine Tumor Is a Rare Cause of Ectopic Adrenocorticotropic Hormone Syndrome With Cyclic Hypercortisolism: A Case Report and Literature Review.
    Zhao YX; Ma WL; Jiang Y; Zhang GN; Wang LJ; Gong FY; Zhu HJ; Lu L
    Front Endocrinol (Lausanne); 2022; 13():808199. PubMed ID: 35250866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors.
    Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
    Pituitary; 2014 Oct; 17(5):464-9. PubMed ID: 24085685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
    Suda T
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
    Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
    Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.